Home

spion Onderhoud Beperken bisoprolol dose atrial fibrillation Soeverein tot nu Onbevredigend

Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial  fibrillation: Results of the MAIN-AF study - ScienceDirect
Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: Results of the MAIN-AF study - ScienceDirect

Bisoprolol (Concor, Bisotrol)
Bisoprolol (Concor, Bisotrol)

Bisoprolol - wikidoc
Bisoprolol - wikidoc

Special considerations for BB usage | Download Table
Special considerations for BB usage | Download Table

A review of rate control in atrial fibrillation, and the rationale and  protocol for the RATE-AF trial | BMJ Open
A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial | BMJ Open

Rate-Control Treatment and Mortality in Atrial Fibrillation | Circulation
Rate-Control Treatment and Mortality in Atrial Fibrillation | Circulation

PDF] Short-Term and Long-Term Effects of Bisoprolol on Chronic Heart  Failure Related to Rheumatic Heart Disease and Atrial Fibrillation |  Semantic Scholar
PDF] Short-Term and Long-Term Effects of Bisoprolol on Chronic Heart Failure Related to Rheumatic Heart Disease and Atrial Fibrillation | Semantic Scholar

Rhythm Control versus Rate Control for Atrial Fibrillation and Heart  Failure | NEJM
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure | NEJM

Association of atenolol, metoprolol and bisoprolol use with central... |  Download Table
Association of atenolol, metoprolol and bisoprolol use with central... | Download Table

Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study |  Revista Española de Cardiología
Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología

The Utility of Beta-Blockers Immediately Prior to Alcohol Consumption in  Order to Prevent Atrial Fibrillation
The Utility of Beta-Blockers Immediately Prior to Alcohol Consumption in Order to Prevent Atrial Fibrillation

Heart rate control by carvedilol in Japanese patients with chronic atrial  fibrillation: The AF Carvedilol study - ScienceDirect
Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study - ScienceDirect

emDOCs.net – Emergency Medicine EducationManagement of Atrial Fibrillation:  Do's and Don'ts - emDOCs.net - Emergency Medicine Education
emDOCs.net – Emergency Medicine EducationManagement of Atrial Fibrillation: Do's and Don'ts - emDOCs.net - Emergency Medicine Education

The mortality benefit of carvedilol versus bisoprolol in patients with  heart failure with reduced ejection fraction
The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction

Drugs used for rate control in atrial fibrillation | Download Table
Drugs used for rate control in atrial fibrillation | Download Table

Bisoprolol (CONCOR) -Uses| Works| Dosage| Precautions| Side Effects
Bisoprolol (CONCOR) -Uses| Works| Dosage| Precautions| Side Effects

Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study |  Revista Española de Cardiología
Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología

JCM | Free Full-Text | Preference and Adherence to a Fixed-Dose Combination  of Bisoprolol–Aspirin and Blood Pressure Control: Results of an  Open-Label, Multicentre Study
JCM | Free Full-Text | Preference and Adherence to a Fixed-Dose Combination of Bisoprolol–Aspirin and Blood Pressure Control: Results of an Open-Label, Multicentre Study

Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension  guidelines for patients with left ventricular hypertrophy to diminish the  ventricular arrhythmic risk | Journal of Human Hypertension
Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Journal of Human Hypertension

Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial  fibrillation: Results of the MAIN-AF study - ScienceDirect
Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: Results of the MAIN-AF study - ScienceDirect

Comparison of heart rate reduction effect and safety between bisoprolol  transdermal patch and bisoprolol fumarate oral formulation in Japanese  patients with persistent/permanent atrial fibrillation (BISONO-AF study) -  ScienceDirect
Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study) - ScienceDirect

Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients:  Is There Room for Improvement? | Journal of the American College of  Cardiology
Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? | Journal of the American College of Cardiology

Beta-blockers for cardiovascular conditions: one size does not fit all  patients - bpacnz
Beta-blockers for cardiovascular conditions: one size does not fit all patients - bpacnz

Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study |  Revista Española de Cardiología
Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología

Bisoprolol for treatment of symptomatic patients with obstructive  hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in  hypertrophic cardiomyopathy) study - International Journal of Cardiology
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study - International Journal of Cardiology

Incidence of postoperative atrial fibrillation in transdermal β-blocker  patch users is lower than that in oral β-blocker users after cardiac and/or  thoracic aortic surgery | SpringerLink
Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery | SpringerLink

Management of Atrial Fibrillation in Patients 75 Years and Older: JACC  State-of-the-Art Review | Journal of the American College of Cardiology
Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review | Journal of the American College of Cardiology